Micro Systemation AB Series B
Micro Systemation AB (publ), together with its subsidiaries, provides forensic technology for mobile device examination and analysis in Sweden and internationally. The company offers XRY software products that include XRY logical, a software solution that enables investigators to access and recover live and file system data from the device on the crime scene; XRY Physical, a software solution, wh… Read more
Micro Systemation AB Series B (0FBM) - Net Assets
Latest net assets as of December 2021: Skr90.80 Million SEK
Based on the latest financial reports, Micro Systemation AB Series B (0FBM) has net assets worth Skr90.80 Million SEK as of December 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr206.50 Million) and total liabilities (Skr115.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr90.80 Million |
| % of Total Assets | 43.97% |
| Annual Growth Rate | -5.66% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 17.14 |
Micro Systemation AB Series B - Net Assets Trend (2017–2021)
This chart illustrates how Micro Systemation AB Series B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Micro Systemation AB Series B (2017–2021)
The table below shows the annual net assets of Micro Systemation AB Series B from 2017 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | Skr90.80 Million | +2.84% |
| 2020-12-31 | Skr88.30 Million | +16.09% |
| 2019-12-31 | Skr76.06 Million | -30.92% |
| 2018-12-31 | Skr110.09 Million | -3.94% |
| 2017-12-31 | Skr114.61 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Micro Systemation AB Series B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 29.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr58.52 Million | 64.45% |
| Common Stock | Skr3.83 Million | 4.22% |
| Other Components | Skr28.45 Million | 31.33% |
| Total Equity | Skr90.80 Million | 100.00% |
Micro Systemation AB Series B Competitors by Market Cap
The table below lists competitors of Micro Systemation AB Series B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Canyon Resources Ltd
AU:CAY
|
$63.82 Million |
|
Biosyent Inc.
PINK:BIOYF
|
$63.83 Million |
|
FLITTO Inc
KQ:300080
|
$63.84 Million |
|
San Lien Technology
TWO:5493
|
$63.84 Million |
|
Windlas Biotech Limited
NSE:WINDLAS
|
$63.73 Million |
|
Gas Plus S.p.A.
LSE:0EMK
|
$63.72 Million |
|
Imagicaaworld Entertainment Limited
NSE:IMAGICAA
|
$63.70 Million |
|
ShareHope Medicine Co Ltd
TWO:8403
|
$63.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Micro Systemation AB Series B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 88,296,000 to 90,800,000, a change of 2,504,000 (2.8%).
- Net income of 34,800,000 contributed positively to equity growth.
- Dividend payments of 36,937,000 reduced retained earnings.
- Other factors increased equity by 4,641,000.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr34.80 Million | +38.33% |
| Dividends Paid | Skr36.94 Million | -40.68% |
| Other Changes | Skr4.64 Million | +5.11% |
| Total Change | Skr- | 2.84% |
Book Value vs Market Value Analysis
This analysis compares Micro Systemation AB Series B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Micro Systemation AB Series B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 38.33%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.45%
- • Asset Turnover: 1.61x
- • Equity Multiplier: 2.27x
- Recent ROE (38.33%) is above the historical average (26.96%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 46.15% | 17.53% | 1.51x | 1.75x | Skr41.43 Million |
| 2018 | 25.20% | 9.13% | 1.58x | 1.75x | Skr16.74 Million |
| 2019 | 6.70% | 1.66% | 1.62x | 2.50x | Skr-2.51 Million |
| 2020 | 18.42% | 5.24% | 1.64x | 2.14x | Skr7.43 Million |
| 2021 | 38.33% | 10.45% | 1.61x | 2.27x | Skr25.72 Million |
Industry Comparison
This section compares Micro Systemation AB Series B's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Micro Systemation AB Series B (0FBM) | Skr90.80 Million | 46.15% | 1.27x | $63.78 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |